___ ___ _______________ ________
/ / / / / _____________/ / ___ |
/ / / / / / / / | |
_ / / / / / / / / | |
|_| / / / / / / / / | |
_ / /__________/ / / /______ / /______| |
| | / ___________ / / _______/ / ________ |
| | / / / / / / / / | |
| | / / / / / / / / | |
| | / / / / / / / / | |
| | / / / / / /_____________ / / | |
|_| /__/ /__/ /________________/ /__/ |__|



N E W S


|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|||||||||||| Volume 5, Number 9, September 2000 |||||||||||
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


A publication of the INTERNATIONAL HEALTH ECONOMICS ASSOCIATION (iHEA)


**** Back issues of iHEA NEWS are archived on the iHEA WWW homepage: ****
**** < http://healtheconomics.org> ****


EDITORIAL BOARD


W. David Bradford, Ph.D.
Center for Health Care Research, Medical University of
South Carolina
Jim Burgess, Ph.D.
Management Science Group, Department of Veterans Affairs



NOTES TO CONTRIBUTORS


The editors must hear from you so that iHEA NEWS can effectively serve
as a medium of communication for iHEA members. We are soliciting
contributions from all members who have information relevant to the
membership at large. There are a number of specific items we are seeking:


* Announcement of job openings;
* Announcement of conferences or seminars in health economics;
* Calls for papers by journals and book editors;
* Announcements of new appointments and promotions;
* Articles describing activities or new initiatives at your
institution, Center or firm (perhaps describing your departmental or
university programs in health economics, discussing new pedagogical tools
used in health economics education, describing new governmental policy
initiatives or programs, and so forth).


Please send any contributions via e-mail to the editors: W. David
Bradford <bradfowd@musc.edu> or James Burgess <burgess@world.std.com>.


|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|||||||||||||||| Contents for the Issue |||||||||||||||||
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



FEATURE ARTICLES

NEW PUBLICATIONS FROM THE OFFICE OF HEALTH ECONOMICS


iHEA AND GENERAL ANNOUNCEMENTS

iHEA 2001 CONFERENCE UPDATE
ROBERT WOOD JOHNSON HEALTH POLICY FELLOWSHIPS


JOBS

ABT ASSOCIATES, INC.
AMERICAN COLLEGE OF RADIOLOGY
ASTRAZENECA
BENCH INTERNATIONAL
EVIDENCE RESEARCH UNIT
UNIVERSITY OF HEIDELBERG
KAPLAN SCIENTIFIC
UNIVERSITY OF KEELE
MCMASTER UNIVERSITY -- DIRECTOR OF CHEPA
MEDICAL UNIVERSITY OF SOUTH CAROLINA
MENTORING AND EDUCATION FOR MENTAL HEALTH SERVICES RESEARCH
UNIVERSITY OF MIAMI
MOUNT SINAI SCHOOL OF MEDICINE
UNIVERSITY OF NEWCASTLE
OXFORD OUTCOMES
RESEARCH TRIANGLE INSTITUTE
ROGER STEPHENS AND ASSOCIATES
RUTGERS UNIVERSITY
SCHERING AG
UNIVERSITY OF SOUTHERN CALIFORNIA
TMP WORLDWIDE
WORLD BANK


CONFERENCES

CHSPR ANNUAL HEALTH POLICY CONFERENCE
CONSOLIDATION AND COMPETITION IN THE PHARMACEUTICAL INDUSTRY
MEASURING AND VALUING HEALTH FOR ECONOMIC EVALUATION

SEVENTH NORTHEAST REGIONAL HEALTH ECONOMICS RESEARCH SYMPOSIUM


FORTHCOMING ARTICLES

HEALTH ECONOMICS VOL. 9(5) JULY 2000
JOURNAL OF HEALTH ECONOMICS, VOL 19 (5), SEPT 2000
HEALTH CARE MANAGEMENT SCIENCE VOL 3 (3)


SUBSCRIPTION AND MEMBERSHIP INFORMATION



-------------------------------------------------------------------------
This newsletter is typeset in Courier 10 point font, and reads best
that format. If the document is not well-aligned, reset your mail
reader to display a non-proportional font (such as Courier).
-------------------------------------------------------------------------

=========================================================================
FEATURE ARTICLES
=========================================================================

NEW PUBLICATIONS FROM THE OFFICE OF HEALTH ECONOMICS

The Office of Health Economics (OHE) has published six new books during
the period May-September 2000. Brief summaries of these are listed below.

The OHE is based at 12 Whitehall, London, SW1A 2DY, England; telephone
+44 20 7930 9203; website: www.ohe.org. E-mail enquiries about the
OHE's research may be directed to Jon Sussex (Associate Director) at:
jsussex@ohe.org. Enquiries about OHE publications should be directed
to Elizabeth Aulsford at: laulsford@ohe.org


BENCHMARKING AND INCENTIVES IN THE NHS
By Paul Grout, Andrew Jenkins and Carol Propper

Can health service funding be linked to benchmarked targets backed by
strong incentives - such as more funding, pay and access to other
resources - for those working in it? Benchmarking compares operational
practices and performance across organisations in order to identify ways
to improve. The UK National Health Service (NHS) has introduced reference
costs and a range of clinical and other performance indicators by which
the performance of hospitals and others are to be judged. But past
use of benchmarking in the NHS - the naming and shaming of a few
outliers - has been inadequate.

Paul Grout, Andrew Jenkins and Carol Propper (of the Centre for Market
and Public Organisation at the University of Bristol) consider the theory
and practice of the use of benchmarking by regulators in the utilities,
by the government in education and other public bodies, and by the
private sector. What does this tell us is achievable in the NHS?
They conclude that there are strong arguments for the use of high-powered
incentives attached to benchmarks in the NHS. Experience in the
regulation of privatised utilities suggests that it would be dangerous
to wait for an ideal system. Introducing less aggressive high-powered
incentive structures quickly is the best way forward.


PRICES, COMPETITION AND REGULATION IN PHARMACEUTICALS: A CROSS-NATIONAL
COMPARISON
By Patricia Danzon and Li-Wei Chao

International drug price comparisons have been used to argue that
countries with strict price regulation have lower prices than countries
with less restrictive price regulation, such as the UK, or no regulation,
as in the US. In this book, Professor Patricia Danzon and Li-Wei Chao
challenge this conventional wisdom. Using a comprehensive set of 1992
data for all community pharmaceutical sales across seven countries their
findings include that:

· Previous price comparisons have been biased by the use of small,
unrepresentative samples, sometimes unweighted, and usually excluding
generics. Comparisons that omit generics yield biased estimates of the
overall average cost of therapy under different regulatory regimes;

· Price comparisons are highly sensitive to choice of weights.
US prices, using US quantity weights, were the same as Canadian prices.
Using Canadian quantity weights, they were twice Canadian levels;

· Generic competition significantly lowers prices in countries with
free or moderate regulation (US, UK, Canada, Germany), but is ineffective
and even counterproductive in countries with strict regulation (France,

Italy and Japan).


MANAGING TO DO BETTER: GENERAL PRACTICE IN THE 21ST CENTURY
By Gordon Moore

Professor Gordon Moore of Harvard University Medical School argues that:

· General medical practitioners (GPs) in the UK need to become care
managers if they are to rise to the challenge of the new national health
system sought by the government's reforms, and win the greatest gains in
health for their populations;

· The value of traditional general practice is under threat from
nurses, pharmacists, the internet and new self-test technologies.
The role of care manager provides a natural opportunity for GPs to
enhance their worth to the health care system. If general practice
fails to adjust and move 'upstream', its future is uncertain.


THE ROAD TO SUSTAINABILITY IN THE UK AND GERMAN BIOTECHNOLOGY INDUSTRIES
By Hannah Kettler and Steven Casper

This joint study by Dr Hannah Kettler (OHE) and Dr Steven Casper
(Wissenschaftszentrum Berlin) finds that the UK and German biotechnology
industries are similar only in terms of the number of companies in each.
The UK industry is older and has larger companies than the German.
The UK industry also focuses much more on therapeutics than the German
industry, where most of the emphasis is on platform technologies and
diagnostics. Both countries' industries remain well behind the US,
however, in terms of size and numbers of products on the market.

The key explanatory factor for the different developments of the UK and
German industries is differences in their institutions supporting
competency development in finance, staffing and technology transfer.
Biotechnology companies, and hence policy makers, in the two countries
confront different issues in their future development. German policies
will have to become more diffused to respond to the increasingly
diversified needs of the different companies in their industry.
In the UK the more pressing problem is to address supply and scale
related factors in the availability of finance (in the period before
an initial public offering (IPO) becomes feasible), skilled managers
and technology transfer offices.


SURGICAL RESEARCH AND DEVELOPMENT IN THE NHS: PROMOTION, MANAGEMENT AND
EVALUATION
Edited by Katharine Johnston and Jon Sussex

This compilation of papers by clinicians, managers and economists,
analyses the particular problems of ensuring that sufficient, high
quality surgical research and development (R&D) is carried out in the
UK National Health Service (NHS). Among the many issues discussed are:

· Surgical R&D can be more difficult to carry out well than R&D
involving medicines;

· The NHS is short of surgeons and other health care professionals
trained in research methods and ready to apply them to improving surgery;

· Surgeons and their teams need to be better rewarded for undertaking
research. This does not necessarily mean money for researchers.
Freeing-up time for research would also be valuable.

Contributors are: Professors Sir Miles Irving, Al Aynsley-Green,
Peter Bell, Martin Buxton, John Gabbay and John Wallwork; Dr Paul Watson
and Katharine Johnston.


IMPROVING POPULATION HEALTH IN INDUSTRIALISED NATIONS
Edited by Jon Sussex

On 6th December 1999, the OHE held a conference to consider which of the
major factors that drive improvements in the health of industrialised
nations' populations will be most important over the next 100 years.
What have been the lessons from the 20th century? This book presents
the original papers by international experts from that conference.
Each chapter looks at one of the major drivers of better population
health: medical care, nutrition, individual behaviour, physical and
social environment. Key points are:

· Medical advances contributed 10-20% of improved life expectancy
during the 20th century and will probably have a greater role in the 21st;

· Improvements in nutrition and hygiene were dominant factors in the
past and will continue to be important;


· The influence of the social environment, especially inequality and
particularly as it affects childhood, is likely to be increasingly
significant.

Contributors are: Professors Christine Godfrey, Clyde Hertzman, Johan
Mackenbach, Sir Michael Marmot and Mark McCarthy; Dr Michael Rayner;
Jon Sussex and Peter Yuen.


=========================================================================
iHEA ANNOUNCEMENTS
=========================================================================

iHEA&Mac226;s Third World Conference, York, 22 - 25 July 2001

UPDATE

Keynote Speakers: We are pleased to confirm that Professor Angus Deaton,
Dwight D Eisenhower Professor of International Affairs, Princeton
University, has agreed to give a keynote speech at the conference.
An abstract of his presentation, together with that of our other
keynote speaker, Professor Amartya Sen, will be published in our
Third Announcement and Registration Package, which will be mailed out
in October.

Student Prize and Poster Prize Competitions: We are pleased to announce
the Student Prize Competition and the Poster Prize Competition at the
York Conference:

Student Prize Competition: A student prize competition has been
organised to encourage the participation of graduate students at the
conference. The winner of the 1st prize will receive a conference
fee waiver, $500 towards travel and accommodation and a copy of The
Handbook of Health Economics. The 2nd Prize winner will received
a conference fee waiver and $250 towards travel and accommodation and
the Third Prize winner a conference fee waiver. All prizewinners
will also be given the opportunity to publish their paper in
Health Economics. A committee chaired by Paul Dolan, University of
Sheffield (UK) will adjudicate papers.

Students should make an open abstract submission by 30 November 2000
and indicate that they wish to be considered for the student prize.
If their abstract is accepted, a full version of the paper will be
required by 15 April 2001, for inclusion in the competition.
Proof of full time student status will be required. The committee
will announce their decision by 31 May 2001.


Poster Prize Competition: Poster presentations will play an integral
part in the iHEA 2001 conference. This will provide an opportunity
for those who are unable to give an oral presentation to present
their work. Consequently, efforts have been made to give sufficient
time and space to posters during the conference (facilities in our
exhibition area will allow us to display up to 200 posters at a time).

A prize of $1000 will be awarded to the best poster, with prizes of
$500 and $250, respectively, to the two best runners up. Prizes
will be awarded by an international committee, chaired by Adam Oliver,
Office of Health Economics (UK).

Further information, plus detailed guidelines for poster presentations
and deadlines for submission will be published in our Third Announcement,
which will be mailed out in October and on our website
(www.ihea2001york.org.uk) soon.


---------------------------------

ROBERT WOOD JOHNSON HEALTH POLICY FELLOWSHIPS

Deadline is November 17, 2000 for Nominations for
Robert Wood Johnson Health Policy Fellowships 2001

The Robert Wood Johnson Health Policy Fellowships Program seeks to
develop the capacity of mid-career health professionals in academic and
community-based settings to assume leadership roles in health policy and
management. The program is funded by The Robert Wood Johnson Foundation
and conducted by the Institute of Medicine (IOM) of the National Academy
of Sciences. Six Fellows participate each year in a September-to-August
program of orientation and full-time work experience in Washington, DC.
Fellows are selected from: (1) academic faculties in medicine, dentistry,
the biomedical sciences, nursing, public health, health services

administration, the allied health professions, economics, and other
social sciences; and (2) organized delivery systems such as HMOs and
other community-based providers and institutions. Fellows are paid
annual stipends equal to their salaries prior to entering the program,
up to $75,000 per year. Nominations are made by chief executive officers
of academic health centers and community-based health care organizations
and agencies. Nominations are due at the IOM by November 17, 2000 for
Fellows entering the program in September 2001.

For an abstract or the full text of the Call for Nominations, visit The
Robert Wood Johnson Foundation Web site, http://www.rwjf.org. Once at the
site, click on "Applying for a Grant," then "List of Open Calls for
Proposals."


=========================================================================
JOBS
=========================================================================

ABT ASSOCIATES INC.

Abt Associates Inc. seeks applications for the position of Francophone
Country Research Manager for the Commercial Market Strategies Project
Research, Monitoring and Evaluation Team. The position will be based
in the Washington, D.C. area, and applications will be accepted only
from U.S. citizens or legal residents documented to work in the U.S.
for the long term.

Background:

Commercial Market Strategies (CMS) is a five-year project of the U.S.
Agency for International Development (USAID) Bureau for Global Programs,
Field Support and Research, Center for Population, Health and Nutrition.
The CMS Project is implemented by Deloitte-Touche Tohmatsu, in
collaboration with Abt Associates Inc., the Meridian Group and Population
Services International. The objective of the project is to increase
the use of family planning and other health products and services
through private sector partners and commercial strategies.

The CMS Project Research, Monitoring and Evaluation (RME) team is
looking for a Francophone Country Research Manager to manage, implement
and provide administrative and technical support for CMS project
research activities in Francophone countries where CMS is operating.

Duties:

· Provide support to country research activities in Francophone
(and some Anglophone) countries
· Specific duties: develop scopes of work and research designs,
review country workplans and research scopes of work, prepare
and evaluate research budgets, monitor implementation of
project activities, communicate with in-country staff, review
research reports, prepare questionnaires, field surveys
including training of survey staff, monitor performance of
in-country research suppliers, analyze data sets and prepare
reports on research findings
· Assist Senior staff with, and carry out if necessary, core
research studies and monitoring and evaluation duties as
needed and indicated by Research Director
· Assist in preparing contract reports, including workplans, annual
and semi-annual reports and budgets
· Provide technical assistance to country programs, including
overseas travel, if indicated
· Assist Research Director, Deputy Research Director and other
staff as needed

Desired Skills:
· At a minimum, MPH in Public Health or MA/MS/MPA in Economics,
Bio-statistics, Public Policy, Demography or related
quantitative social science discipline
· 2 years experience in data collection, analysis and management
of research and/or monitoring and evaluation activities
· Willingness to travel overseas as needed to support country
research activities
· French language proficiency required, ability to function in a
francophone environment on a regular basis
· Experience with and proficiency in data analysis and the use of
statistical software packages for data analysis (e.g.:

SAS, Stata, SPSS, Limdep)
· Ability to work well in a team environment
· Strong communication and presentation skills, both verbal and
written.
· Previous work experience for USAID funded projects, including
familiarity with USAID policies, procedures, and results
reporting.

Send resume and cover letter highlighting experience and qualifications
related to the above position description and requirements to:
William Sigler at sigler@alumni.nd.edu

Please note that applications that do not include a thoughtful and
responsive cover letter or that demonstrate that the applicant does
not substantially possess the required background and experience will
not be acknowledged.


-----------------------------------------

AMERICAN COLLEGE OF RADIOLOGY
RESEARCH DEPARTMENT

Senior Researcher

The American College of Radiology (ACR) is a major physician specialty
society located in Reston, VA, a suburb of Washington DC. The research
department consists of 4 Ph.D.-level staff (economists, social scientists,
and statisticians) plus 3 more junior staff. The department primarily
undertakes economic and socioeconomic research related to Radiology, but
is increasingly becoming involved in clinical studies. The department
publishes its research in major medical journals, and is funded by the ACR
so staff do not have to obtain "soft money." It has a significant budget
for outside professional services when assistance is needed on projects,
and has funds for members to attend professional society conferences and
make presentations at these meetings.

The department is seeking a senior researcher with interests primarily in
economics or finance. Qualified applicants will have a Ph.D. and at least
2 years experience; or a master's degree and at least 5 years experience,
plus good quantitative skills, programming ability in SAS or another
statistical software package, ability to write a quality professional
journal article or report with only limited supervision, and good oral and
written communications skills.

Current departmental projects, illustrative of those on which the Senior
Researcher will work, include:
* Cost and cost-effectiveness studies, particularly as components of
clinical research studies.
* Comparison of the cost of treating cancer with radiation relative to the
cost of other treatments.
* Studies of the costs and productivity of radiology practices.
* Research on "self-referral"-the consequences in terms of utilization,
cost, and quality that result when physicians have a financial interest
in, and provide, services outside their principal field of practice.
* Studies of the employment market for physicians.

ACR offers excellent benefits. EEO M/F/D/V. Send resume, salary
requirement, and example(s) of reports or papers written to ACR/Human
Resources Department/1891 Preston White Drive/Reston/VA/20191. For
questions about the professional aspects of the position, you may also
contact Jonathan Sunshine, Ph.D., Senior Director for Research,
jonathans@acr.org or 703-648-8924.


------------------------------

ASTRAZENECA

AstraZeneca is now actively recruiting to extend its position as a
powerful force in new investigations of diseases and their
therapeutic solutions. Its global team is being strengthened within
the R&D groups which focus on oncology, cardiovascular and
respiratory therapeutics.

1. Senior Health Economist / Skills Manager

Based: Loughborough
Competitive package, benefits + car

An exciting opportunity for an experienced and capable Health
Economist who has industry experience. Acting as the focus for
development of HEcOR at this site, you'll work locally and globally
with clinical development teams. Eventually, you may build your own
team and assign to them some of the key projects for future
investigations whilst contributing to the building of global
capabilities, methods and standards.

In this important role, you will also be involved in a major priority

drug development project team, shaping strategy and operational
plans. With internal staff, external consultants and agencies, the
team will deliver the required outputs for regulatory, medical and
marketing colleagues to incorporate into their strategic plans.

A graduate in Life Sciences, with an MSc or PhD in HEcOR, you will
have at least 3-5 years experience in the pharmaceutical industry,
coupled with project/team leadership responsibility, ideally gained
in cardiovascular or respiratory disease. Your strategic skills and
your abilities to inspire others and communicate complex ideas to a
broad range of audiences will be excellent. Your
computing/ IT skills will be at the leading edge of current practice.

To apply, please sent your CV ideally by email to Andrew Forrow,
Practice Leader, quoting Ref: 00146DG
Roger Stephens & Associates, Chequers House, I Park Street,
Old Hatfield, Hertfordshire, AL9 5AT, UK.
Telephone: 44 (0) 1707 259333
Fax: 44 (0) 1707 271366
E-mail: rsvp@pharmarecruit.com


2. Health Economics Project Leader

Based: Alderley Park, Cheshire
Competitive package, benefits + car

An opportunity to join a highly competent and growing team which is
engaged in all aspects of HEcOR in oncology and other critical health
conditions, this position offers the successful candidate a role in a
cross-functional group responsible for generation of global health
economic strategies, claims and
deliverable outputs throughout a product's life cycle. As the Global
R&D representative, your creation and implementation of economic and
patient outcome measurements (incl. QoL) will be valuable in clinical
trials and in studies outside the clinical programme. Value for
Money claims will be a particular focus.

In this developmental role, you will be immediately effective, by
contributing your HEcOR training and project management expertise,
contributing your HEcOR training and project management expertise,
progress in this expanding function at the heart of a world-leading
company.

A graduate with a background in clinical research, statistics or
economic modelling, you will understand the whole drug discovery/
development process. Your postgraduate studies will have
demonstrated your highly inquisitive nature and applied your
conceptual thinking, innovativeness, results-orientation and
independence.

To apply, please sent your CV ideally by email to Andrew
Forrow, Practice Leader, quoting Ref: 00147DG.
Roger Stephens & Associates, Chequers House, I Park Street,
Old Hatfield, Hertfordshire, AL9 5AT, UK.
Telephone: 44 (0) 1707 259333
Fax: 44 (0) 1707 271366
E-mail: rsvp@pharmarecruit.com


------------------------------

BENCH INTERNATIONAL

Senior Health Outcomes Scientist, Cardiovascular Diseases Team (Major
Pharmaceutical-Midwest): Provide health outcomes support for new and
existing compounds under rigorous evaluation by the global cardiovascular
health economics and strategic pricing product team. Primary
responsibility for the design of treatment algorithms, decision
analytic model(s), burden of illness study, instrumentation of
clinical trials, retrospective analyses and other research.
Work with key functional representatives within the team and
affiliates to plan appropriate research to contribute to the
successful commercialization of compounds. Mentor junior researchers.
Seek input from medical, marketing, legal, and health outcomes
representatives to understand geographic requirements for successful
research agenda and execution. Coordinate research processes with
other clinical research professionals (CRAs, systems, statistics,
etc) to ensure completion of studies. Deliver a research and
publication plan that optimizes commercialization of cardiovascular
products. Develop budgets and timelines to resource the plan.
Work with affiliate health outcomes representatives to plan and execute

local research and communication activities. An advanced degree in a
health outcomes related field (e.g. economics, applied epidemiology,
pharmacoeconomics, health services research) required. Pharmaceutical
industry experience is preferred. For full, confidential details
please contact Cheri Buonaguidi, Bench International, ph. (310)-854-9900,
email: cheri@benchinternational.com


Director, Health Economics, Reproductive Medicine, Diabetes,
Anti-infectives (Major Pharmaceutical Corporation-Northeast):
Strategically design/implement economic evaluation programs for
products in development and work with global product and commercial
teams to ensure that programs appropriately determine value, support
pricing and reimbursement, and contribute to successful product marketing.
Formulate and oversee all comprehensive strategies for economic
evaluations including retrospective and prospective cost-effectiveness
studies, quality of life, and cost-of-illness studies. Analyze and
interpret results of studies and assist in developing situation assessment
overviews, targeted economic dossiers and global lifecycle plans.
Requires PhD, MD or equivalent with focus on health economics, QoL,
or epidemiology; 5-6 years in health economics/outcomes research;
4-5 years in research/project management; industry experience preferred.
Demonstrated history of designing analysis plans and modeling evaluations
beyond clinical trials. Superior communications, presentation and
interpersonal skills. Contact Cheri Buonaguidi, Bench International,
Tel 310-854-9900, Fax 310-652-2081, cheri@benchinternational.com


------------------------------------------

EVIDENCE RESEARCH UNIT

The Evidence Research Unit is a growing consultancy working in the
area of evidence-based health care and applied health economics. Our
clients include a wide variety of blue chip and multinational
pharmaceutical companies. Our rapid and continued success in
evidence-based healthcare means we are currently recruiting staff in
the Northwest of England.

PROJECT LEADERS
Responsible for developing, implementing and leading our projects via
interaction with clients and external academic groups. Effective
project management skills and a good understanding of the principles
of evidence-based healthcare / health economics are essential.

HEALTHCARE ANALYSTS /TRAINEE ANALYSTS
Responsible for researching and critically appraising clinical /
health economic info, analysing quantitative and qualitative data and
summarising research into effective presentations and reports.

All positions require as a minimum a Life Science or Health Economics
degree plus a good understanding of evidence based healthcare.

To attract the best candidates we offer an excellent salary, company
pension, profit bonus scheme, private medical health and permanent
health insurance.

Please send a CV and a letter of application with current salary
information to: Caroline Entwistle, Personnel Administrator: CMC UK,
19 King Edward Street, Macclesfield, Cheshire, SK10 1AQ.


------------------------------

UNIVERSITY OF HEIDELBERG

The Medical Faculty at the University of Heidelberg and the research
focus 'Tropical Medicine' invite applications for:

Independent Junior Group Leader Positions (5 years)

1) In the field of tropical infectious diseases, particularly
molecular parasitology or molecular entomology;
2) Health system research, particularly epidemiology of infectious
diseases, economics or public health.


We are seeking applications from outstanding individuals with a
strong background in one of these fields. Applicants should have a
Ph.D., M.D. or an equivalent degree and should not be older than 34.
Appropriate space, positions, and funds for a laboratory and its
operation will be provided. Extramural funding is expected as well as
participation in the SFB 544 'Control of tropical diseases'. The
successful applicant will be specifically encouraged to engage in
collaborative research with clinicians at University hospitals and a

field station in Burkina Faso. Applications (CV, list of
publications, the names of three referees and an outline of past and
future research plans) should be send to:

Frau Kndler, Universitt Heidelberg
Im Neuenheimer Feld 365, 69120 Heidelberg, Germany
(e-mail: dagmar_knoedler@med.uni-heidelberg.de)
(http:/www.hyg.uni-heidelberg.de/tropmed/index.htm)

The deadline for applications is September 30th, 2000.

The University of Heidelberg is an equal opportunity employer.


------------------------------

KAPLAN SCIENTIFIC

Due to the tremendous success of our client's currently marketed products,
their extensive product portfolio and their ambition to be a "TOP 10" U.S.
Pharmaceutical Company, they have the following position available in their
corporate headquarters located in the North East.

ASSOC. DIR. HEALTH ECONOMICS RESEARCH

You will be responsible for generating relevant health economics/health
outcomes (Hecon) information for the company's products. This information
will broaden the profile of product benefit and will assist in
demonstrating the need for resources to U.S. and International
subsidiaries.

REQUIREMENTS MS; PH.D ;1+ years of relevant pharmaceutical or related
industry experience; must have an applied knowledge of health outcomes
science including basic economic analysis, quality of life and other
patient focused endpoints along with exposure to international and
domestic registry/pricing agencies. Will be required to interface
with diverse teams internally (product, clinical, marketing) and
external customers (MCO's, International Registration/Pricing
agencies, outcomes thought leaders and consultants).

SALARY: $ 70.0K-$100.0K base salary dependent on number of years
experience and accomplishments; bonus eligible; extensive benefits
package (primarily company paid); full relocation package.


HEALTH ECONOMICS

Our clients, top-tier pharmaceutical and biotechnology companies
currently have available positions for professionals with experience
in Outcomes Research, Pharmacoeconomics, Epidemiology, Reimbursement
or Managed Care from both the clinical and marketing standpoint.

Requirements: MS, Ph.D., Outcomes Research, Epidemiology, Public Health
or a related discipline. Prior academic, industrial or postdoctoral
experience in the fields of Health Economics/Outcomes Research and
Management are required. Must be eligible to work in the United States.

Compensation: Competitive based on academic credentials and accomplishments
related to the field of Health Economics.

Please forward resume in confidence to (e-mail preferred):

Doreen Rosenblatt
Kaplan Scientific
1010 Washington Boulevard
Stamford, CT 06901
(203) 406-2300 x2012
Fax (203) 406-2315
DOREEN@KAPSCI.COM


------------------------------------------

UNIVERSITY OF KEELE

The health economics unit at Keele would welcome informal enquires
from individuals seeking to pursue a career in health economics.
Individuals in the first instant should contact the head of the unit

Dr Marilyn James
Head of Health Economics (R&D) Unit \ Senior Lecturer
University of Keele
Keele
Staffordshire
ST5 5BG

email m.james@keele.ac.uk
Tel (01782) 583191

at their earliest convenience for an informal discussion.


------------------------------

MCMASTER UNIVERSITY -- DIRECTOR OF CHEPA

Director, Centre for Health Economics and Policy Analysis
McMaster University, Hamilton, Ontario, Canada

McMaster University is "research intensive" and perennially rated as the
most innovative university in Canada. McMaster's outstanding Centre for
Health Economics and Policy Analysis (CHEPA) seeks a Director. CHEPA is a
"national treasure" with a strong international reputation (External Review,
November 2000), with 10 full-time faculty and 20 research staff who support
its mission to foster excellence in creating and communicating relevant
knowledge in health economics and health policy analysis.


The successful candidate will hold a PhD/MD or equivalent and have a
substantial research and publication record in the disciplines of health
economics and/or policy analysis, with proven ability to foster excellence
in research and teaching. Responsibilities include coordinating the research
and educational activities of CHEPA while maintaining a strong personal
research program and teaching graduate and undergraduate students in health
economics or health policy analysis. The leader oversees strategic planning,
and acts as liaison to the University, the Ontario Ministry of Health, and
other supporting organizations.

The successful candidate will be recommended for an academic appointment
with rank and salary appropriate for experience, and, if appropriate,
considered for a clinical appointment in one of the teaching hospitals
affiliated with McMaster.

Applications and nominations including a curriculum vitae, a statement of
research interests and academic goals, and the names of three referees may
be forwarded to: Dr. R. Joffe, Dean and Vice President, Faculty of Health
Sciences c/o Faculty Recruitment Coordinator, Room 2J5, HSC, McMaster
University, 1200 Main Street West, Hamilton, Ontario, Canada L8N 3Z5

For more information about the Faculty visit our Web-site at
http://www.fhs.mcmaster.ca

For information on CHEPA, visit http://www.chepa.mcmaster.ca

McMaster is committed to Employment Equity and encourages applications from
all qualified candidates. This position has been approved by Immigration
Canada for all applicants, regardless of citizenship or Canadian permanent
resident status.


----------------------------------------

MEDICAL UNIVERSITY OF SOUTH CAROLINA

Faculty Position

Department of Pharmacy Practice
College of Pharmacy
Medical University of South Carolina

The Department of Pharmacy Practice of the Medical University of South
Carolina in Charleston is seeking to fill a junior faculty position in
pharmacoeconomics or pharmacoepidemiology. Applicants must have a Ph.D.
in economics, epidemiology, or health services research with strong
preparation in quantitative methods. ABD candidates whose dissertation
project and research interests are well developed and a good "fit" with
the Department's research portfolio will be considered. The Department
has a preference for candidates with research interest in the economics
of drug therapy for patients with complex chronic diseases (such as
AIDS, Diabetes, cancer, or heart disease), or in the clinical
epidemiology of drug therapy for patients with complex chronic diseases
in the community setting. The candidate is expected to establish an
independent, externally funded research program; to collaborate as a
methodological expert with clinical researchers across the MUSC campus,
and to teach courses in outcomes research and applied pharmacoeconomics
to Ph.D. and Pharm.D. students. The appointment will be in the tenure
track at the assistant professor level. Salary will depend on the
candidate's qualifications. Review of applications will begin on
August 15, 2000 and will continue until a candidate is selected.
A November 1, 2000 start date is anticipated.

The Department of Pharmacy Practice is one of two departments in the
College of Pharmacy. The College has 43 full time faculty members, of
which 22 are clinical specialists. The college offers the Ph.D. and
Pharm.D. degrees and provides specialist training for 25 residents
and 5 fellows. College faculty have a rapidly increasing research
program concentrated in four areas of emphasis: 1) Clinical drug
effectiveness; 2) Anti-infective and anti-neoplastic drug efficacy;
3) economic and quality of life impacts of rational drug therapy; and
4) the structural biology of drugs. Much of the research in the
Department of Pharmacy Practice is linked to collaborative projects
with insurers and medical providers to develop and test the effects
of pharmaceutical care innovations at the community level. Currently

there are 180 students in the graduate programs.

Applicants should send a letter of interest, curriculum vitae, and the
names of three references to: Dr. Kit N. Simpson, Pharmacy Search
Committee Chair, Center for Health Care Research, Medical University
of South Carolina, 135 Rutledge Avenue, P.O. Box 25050, Charleston,
SC 29425.

For additional information call Dr. Simpson at 843 876-1243.


----------------------------------------

MENTORING AND EDUCATION FOR MENTAL HEALTH SERVICES RESEARCH

Under the Program Announcement for Mental Health Education Grants
(PAR-97-095) the National Institute of Mental Health recently funded a
program to provide up to 18 months of mentoring, consultation and
education by outstanding senior mental health investigators to junior
faculty interested in mental health services research. The purpose of
the program is to provide junior faculty with the mentoring and technical
assistance they need to produce high quality, fundable mental health
services research projects. This program will provide targeted expertise in:

· Conceptualization and specification of research questions;
· Design, sampling and analysis;
· Cost Benefit/Cost effectiveness techniques; and
· Issues concerning vulnerable populations.

The program is funded to enroll up to 10 talented faculty members in
each of two years, and will target junior faculty in institutions with
limited or no expertise in mental health services research.

This program is a joint venture between Yale University, the University
of Chicago, the University of California at Los Angeles, the University
of Puerto Rico, the University of Illinois at Chicago and the University
of Pittsburgh. The Steering Committee for this project consists of:
Sarah Horwitz, Ph.D., children's mental health services; Naihua Duan,
Ph.D., applied biostatistics with emphasis on survey sampling and study
design; Kenneth Wells, M.D., M.P.H., mental health treatment
effectiveness/outcomes, quality of care; Willard Manning, Ph.D.,
health economics, managed care; Donald Hedeker, Ph.D., applied
biostatistics with emphasis on the analysis of longitudinal data;
Margarita Alegria, Ph.D., minority mental health services use; and
Kelly Kelleher, M.D., M.P.H., mental health issues in pediatric primary
care.

To apply for this program, prospective enrollees must:

· Be a junior faculty member;
· Supply the equivalent of an R03 application (10-20 pages with
specific aims, background, preliminary data and methods)
or an unfunded R01, R03, or K application with reviews;
· Demonstrate support from the Chair of their Department for
continued employment for 12 months and a small amount
of resources, such as release time for research, travel
funds and/or research assistance; and
· Attend two educational conferences.

If you are interested in learning more about this opportunity, please
contact:

Sarah Horwitz, Ph.D., Program Director
Yale University School of Medicine
Department of Epidemiology & Public Health
Phone: (203) 785-2862
Fax: (203) 785-6287
E-mail: patricia.krieger@yale.edu


-------------------------------------

UNIVERSITY OF MIAMI
Department of Epidemiology and Public Health
Associate Professor
Health Economics

Description: The Department of Epidemiology and Public Health, School
of Medicine, is accepting applications for a faculty position (tenure
track or tenured) at the Associate Professor level with a specialization
in health economics. The applicant can anticipate immediate participation
in a variety of presently funded health economics projects. There is also
an expectation that the applicant will design, secure external funding for,
and lead his or her own projects.

Responsibilities: The responsibilities of the position include (1) serve
as a principal investigator and co-investigator of currently funded
economics research projects; (2) design research projects and prepare
research grants and contracts; 3) work effectively with interdisciplinary

faculty and staff; 4) publish research findings in refereed journals;
5) present findings at local, state, national, and international
professional meetings; and 6) teach courses such as health economics,
public policy, and economic evaluation within the department.

Qualifications: Candidates must possess a doctorate in economics and
have at least five years of research experience in health economics,
human resource economics, or related areas of study. An outstanding
publication record is necessary and prior experience as a principal
investigator of funded research projects is desirable. The applicant
must demonstrate that he or she can work collaboratively within a
multi-disciplinary research environment.

Appointment: This position will be at the rank of Associate Professor
(tenure track or tenured). Salary and appointment will be established
commensurate with experience and qualifications. This is a 12-month
appointment that includes standard University benefits. The primary
appointment is in the University of Miami School of Medicine, Department
of Epidemiology and Public Health, with a strong affiliation with the
Health Services Research Center.

The University of Miami is an equal opportunity affirmative action
employer.

Application Procedures: Position #04429. Interested and qualified
applicants should send a resume, 3 letters of reference, and 3 recent
publications to:

Professor David Lee
Recruitment Committee Chair
University of Miami
Department of Epidemiology and Public Health (D93)
1801 NW 9th Avenue, Second Floor
Miami, Florida 33136


-------------------------------------

MOUNT SINAI SCHOOL OF MEDICINE

Assistant Professor, Department of Health Policy
The Mount Sinai School of Medicine of New York University

The Department of Health Policy, The Mount Sinai School of
Medicine, is seeking a health services researcher with training and
experience in economic analysis for the tenure-track position oF
Assistant Professor. Candidates should have a Ph.D. or comparable
doctoral degree, and enjoy working in multidisciplinary project teams.

The faculty member would collaborate with other faculty, including
those in the Institute for Medicare Practice; teach; and develop a
portfolio of externally-funded research. This five-year-old
Department has a strong record of research, primarily in the areas of
improving the quality of care, reducing ethnic/racial disparities,
analyzing organizational arrangements for delivering care, and
conducting cost-effectiveness analyses. The Department also serves as
a resource for quality improvement within the Mount Sanai/NYU Health
System. The successful applicant will be able to participate in these
areas and expand the Department's research according to her/his
interests.

The Mount Sinai School of Medicine is an equal opportunity and
affirmative action employer, and encourages applications from women
and minority group members. Applicants should submit a letter
indicating research interests, a curriculum vitae, and a recent paper
to Jane E. Sisk, Ph.D., Professor; Department of Health Policy, Box
1077; The Mount Sinai School of Medicine; One Gustave L. Levy Place;
New York, NY 10029-6574, USA, email <jane.sisk@mountsinai.org>, fax 1
212 423 2998, telephone 1 212 659 9567.


-------------------------------------

UNIVERSITY OF NEWCASTLE, UK

DEPARTMENT OF EPIDEMIOLOGY & PUBLIC HEALTH
SCHOOL OF HEALTH SCIENCES

SENIOR LECTURER IN HEALTH ECONOMICS
stlg32,510 - stlg36,740

The School of Health Sciences seeks a suitably qualified candidate
for a Senior Lecturer post in the Department of Epidemiology &
Public Health. The post has fallen vacant following the promotion
of Dr David Parkin to a Chair at City University, London, and is
tenable immediately.

We seek candidates with a proven track record of research and

scholarship in health economics, with a history of attracting
external funding. You will have a leading role in the Health
Economics Research Group within the School, which undertakes
research into economic modelling of the production of health and
health care, including applications in efficiency measurement,
decision analysis, costing and health status measurement; and
economic evaluation of health care, involving collaborative studies
on a range of health care interventions. Other specialist research
interests in the Department of Epidemiology and Public Health
include the following: cardiovascular and stroke epidemiology;
environmental epidemiology; health promotion; and foetal and
perinatal epidemiology. You should have a higher research degree and
you should be able to demonstrate achievement in research and the
ability to manage programmes of work, staff and budgets. You will
have experience of health economics teaching, course development and
management at undergraduate and postgraduate level. The Department
and the School of Health Sciences is a strongly multidisciplinary
grouping; versatility and commitment to working within this
environment will be crucial.

For an informal discussion about the post please contact either
Professor Richard Thomson (Tel: 0191 222 8760, e-mail:
richard.thomson@ncl.ac.uk), or Paul McNamee, Lecturer in Health
Economics (Tel: 0191 222 7214, e-mail: paul.mcnamee@ncl.ac.uk).

0191 222 5429 (24 hour answerphone) quoting reference A330A or write
to Human Resources Section, Reference A330A, University of
Newcastle, 1 Park Terrace, Newcastle upon Tyne, NE1 7RU. Closing
date for applications is 29th September 2000.


DEPARTMENT OF EPIDEMIOLOGY & PUBLIC HEALTH
SCHOOL OF HEALTH SCIENCES

RESEARCH ASSOCIATE (16,775 - 25,213)
OR SENIOR RESEARCH ASSOCIATE (23,256 - 30,967)
IN HEALTH ECONOMICS


A 3 year Research Associate/Senior Research Associate appointment is
available to work on projects involving the application of economic
evaluation techniques. Initially you will undertake two cost utility
studies: the first examining the use of first trimester ultrasound
screening; the second considering the role of early surgical care for
intracerebral haemorrhage. There will also be opportunities to
contribute to National Institute of Clinical Excellence (NICE)
appraisals and develop work related to the candidates own specific
interests.

You will join an existing research group with an established record of
excellence. You must have good interpersonal skills and a degree in
either economics or health economics. For appointment at Senior
Research Associate level, previous research experience and a good
publications record is also essential.

To apply please send a letter of application, a CV and the names and
addresses of two persons from whom a reference may by obtained, to
Lorna Hutchinson, Department of Epidemiology and Public Health, The
Medical School, Framlington Place, University of Newcastle, NE2 4HH.
The closing date for receipt of applications is September 8 2000. An
information pack about the post is also available from this address or
by telephoning 0191 222 8813. For a preliminary discussion, contact
Paul McNamee, Lecturer in Health Economics (Tel: +44 (0)191 222 7214;
Fax: +44 (0)191 222 6043; or e-mail: Paul.McNamee@ncl.ac.uk). Further
general information about health economics activities at Newcastle is
available at http://www.ncl.ac.uk/deph/hegroup.html.
General information about the department is available at


http://www.ncl.ac.uk/deph/index.html.


-------------------------------------

OXFORD OUTCOMES

Senior consultant in health outcomes research

We specialise in health outcomes assessment, health economics, and
quality of life (QoL) research; undertaking consultancy projects for
international clients in the pharmaceutical sector.

We seek a psychologist, sociologist, or health economist to join our
small, but growing, team. As a minimum requirement you should have a

post-graduate qualification in psychology or related subject, and
ideally have relevant work experience. Familiarity with SPSS would be
very useful.

This is a full-time position with great potential for professional
growth. right person for us we can build you and your ambitions into
our team.

Salary is negotiable. If you are interested please submit a CV, and
details of current salary to:

Paul Quarterman, Oxford Outcomes, Bury Knowle Coach House, North Place
Old High Street, Headington, Oxford OX3 9HY


------------------------------

RESEARCH TRIANGLE INSTITUTE
CENTER FOR ECONOMICS RESEARCH


RTI is an independent, nonprofit, multidisciplinary research institute
founded by three universities - University of North Carolina at Chapel
Hill, Duke University, and North Carolina State University - to conduct
impartial science-based research for government and industry.
RTI seeks economists who have or are about to receive a Ph.D. in
economics or related fields. We are also interested in candidates
with relevant experience beyond the Ph.D. in industry, government,
academia, or consulting. We prefer individuals with an applied/empirical
focus and strong quantitative skills. Experience with Census Department
micro-data sets is a plus because of access to the Triangle Census
Research Data Center at Duke University, Durham, N.C. Successful
candidates must have the ability to correctly conceptualize economic
problems, design and implement appropriate research methods, apply
quantitative techniques, publish in peer-reviewed journals, and
communicate clearly both orally and in writing with clients and
staff including nontechnical audiences. Candidates selected will
lead ongoing and new projects and contribute to grant and contract
proposals to government agencies and other funding sources.
Individuals are sought in the following areas.

Health Economics
Labor Economics

Conduct studies on the economics of public health interventions, health
care markets, economics of alcohol, tobacco and other drugs of abuse,
and economic evaluation of pharmaceuticals and devices. Areas of special
interest include managed care, health care financing, health care policy
and reform, public health, prevention, project evaluation,
cost-effectiveness and cost-benefit analysis, valuation of health
benefits, and the industrial organization of health care markets.

Contact: Gary A. Zarkin, Ph.D., Health and Human Resource Economics
Program.

Interested individuals are encouraged to send a letter of interest,
curriculum vitae, and writing sample to the appropriate contact at the
Center for Economics Research, Research Triangle Institute, P.O. Box
12194, Research Triangle Park, NC 27709-2194. RTI staff will be
available for interviews at the annual AEA meetings in New Orleans,
LA, January 5-7, 2001. RTI is an equal opportunity employer/affirmative
action employer/M/F/D/V.


-------------------------------------

ROGER STEPHENS AND ASSOCIATES

Apply your full range of economic and clinical experiences
with a global market leading company, in the newly-created role of:

Head of Development Unit
Health Economics & Outcomes Research

stlgcompetitive + major company benefits, UK base/global remit

Reporting to the Head of Global HEOR, you will join a highly
authoritative, credible and professional medical group which is based
west of London. You will be responsible for all Health Economics and
Outcomes Research activities either within a therapeutic area or for
the whole of the portfolio, in support of Development activities, from
phase II on. The responsibility is global. Contact with colleagues
throughout Europe and the USA will be extensive. You will directly
contribute to portfolio/life cycle management and the registration of
new drugs.

Your specific responsibilities will include:

* budget preparation and management
* hands-on project planning and implementation

* driving interactions with opinion leaders and, internally, with all
departments which interface with clinical development
* integration of the Development unit within the global HEOR function
* training and development within the functional team

The ideal person will offer a medical and/or economic
education, followed by 7-10 years clinical or business experience.
He/she will bring national, and ideally some global, experience in
support of clinical trial design and the integration of Quality of
Life and other outcomes measures into development plans.

You will join an open-minded, collegial Company that is
process- and success-oriented. It has a 'listening' culture which
favours decisiveness. The successful candidate will be highly
conversant with all aspects of HEOR, having spent at least five years
in an industrial or leading academic environment. He/she will be a
self-motivated leader, an accomplished team player who ideally is
sensitive to different cultural backgrounds.

To apply, please sent your CV ideally by email as a Word
document with a covering letter quoting Ref: 00136DG to Andrew Forrow
at Roger Stephens & Associates, who is advising.

Roger Stephens & Associates, Chequers House, I Park Street,
Old Hatfield, Hertfordshire, AL9 5AT, UK.
Telephone: 44 (0) 1707 259333
Fax: 44 (0) 1707 271366
E-mail: rsvp@pharmarecruit.com


-------------------------------------

RUTGERS UNIVERSITY

Senior Policy Analyst/Health Economist

The Center for State Health Policy at Rutgers University seeks highly
qualified health economist or health services researcher for
position of Senior Policy Analyst. The Center, supported by a
five-year grant from the Robert Wood Johnson Foundation, provides
timely, policy relevant information and research findings to support
health policy making and to make scholarly contributions to the
field. This is a calendar year non-tenure track faculty appointment.
The Senior Policy Analyst designs and implements analyses that
address state health policy issues, and generates external funding
for Center research. The Center provides a dynamic
inter-disciplinary environment with excellent research and data
support. Requires doctoral degree in economics, health economics,
health services research, or related field, with excellent
quantitative skills, prior research experience in quantitative health
services analysis or health policy studies, and a strong publication
record. Preference given to those with a record of significant work
in health care financing, access to health services for under served
and minority populations, or long-term care policy. Salary and rank
based on qualifications and experience. Send resume to: Director,
Center for State Health Policy, Rutgers University, 317b George St.,
Suite 400, New Brunswick, NJ 08901-2008.


------------------------------

SCHERING AG

Health Economist for the Area of International Project
Management / Outcomes Research Schering AG, Berlin.

Schering AG is seeing to employ a Health Economist for
the Area of International Project Management. Your
job would consist of conducting economic analyses as
part of the activities of our Outcomes Research. This
would encompass planning international
pharmacoeconomic studies from Phase II of drug
development and providing support when these studies
are carried out. In this connection you will work
together with project teams to analyse the economic
aspects of new therapies and diagnostic procedures.
Your responsibilities will include leading
international teams and organising collaborations with
external advisers and CROs. In addition, you will give
lectures at our subsidiaries and specialist functions,
and present pharmacoeconomic studies at congresses and
symposia.

Your qualification is a university degree, preferably
in the field of health economics or economics; a Ph.D.
is desirable. You have experience with
pharmacoeconomic analyses, an understanding of the

drug development process, and knowledge of health
economics and different health care systems. You also
possess a sound knowledge of cost-benefit analyses for
health care systems. The special nature of this job
requires the capability of doing independent
scientific work and team-oriented work. In this you
show the ability to present your work in clear,
concise language, both in writing and speaking, as
well as a sense of responsibility, negotiating talent,
and the willingness to cooperate with others. Further
requirements are very good skills in oral and written
English and very good PC skills (with simulation
software, e.g. Data Tree). Taking business trips is a
necessary part of the job.

We offer you: a challenging position that will give
you the chance to work independently and realise your
own ideas within a team. We also offer you good
opportunities for further education and the extensive
benefits of a large modern company.

We are a research-oriented pharmaceutical company. Our
objective is to make a lasting contribution to the
progress of medical science and to improve the quality
of human life via the medium of innovative ideas. We
are engaged in the development of highly advanced
medical specialities: contrast media, hormone
preparations and therapeutic drugs for the treatment
of severe illnesses. More than 22,500 employees
worldwide are engaged in the pursuit of these
objectives. Health care is our primary objective,
which we approach with due responsibility to man and
the environment for the establishment of a future
worth living.

Please send your application, stating your desired
salary, to: Schering Aktiengesellschaft,
Personalabteilung FO, 13342 Berlin

Initial queries will be answered by Frau Rasokat,
Telephone: (0 30) 4 68-1 70 46
Email: Birgit.Rasokat@Schering.de

Visit our web site: http://www.Schering.de


-----------------------------------

UNIVERSITY OF SOUTHERN CALIFORNIA

Tenure-Track Position, Department of Pharmaceutical Economics and Policy,
School of Pharmacy, University of Southern California - The Department
of Pharmaceutical Economics and Policy offers a 12-month tenure track
position for an individual with expertise in health economics,
econometrics, health services research or related field. The successful
applicant should have a Ph.D. in economics, health services research,
health policy research or related field. Candidates for Associate Professor
appointment should have a research and publication profile consistent
with national recognition. The ideal candidate would have experience
and/or training in drug related issues, technology assessment,
cost-effectiveness and cost-utility analysis and health outcomes research.
The successful candidate will be expected to contribute to the Department's
teaching program in both the professional (PharmD) and graduate programs.
Successful candidates will have an opportunity to work with colleagues
within the Department, the Department of Clinical Pharmacy, the
Department of Economics and the Schools of Gerontology and Planning,
Policy and Development.

Candidate screening will begin immediately. Appointment will be effective
as of July 1, 2000 or until the position is filled. Minority candidates
are especially encouraged to apply. Salary will be commensurate with
qualifications and rank. Interested persons should send a letter of
interest, a current curriculum vitae and letters of recommendation
from at least four individuals familiar with the applicant's research
and publications to:

Jeffrey S. McCombs, Ph.D.
Associate Professor
Department of Pharmaceutical Economics and Policy
1540 E. Alcazar St., Rm. CHP-140
Los Angeles, CA. 90089-9004
e-mail: jmccombs@hsc.usc.edu


-----------------------------------

TMP WORLDWIDE

RESEARCH PROFESSOR IN HEALTH ECONOMICS

There are not too many times in one's career that opportunities arise
to build a well-respected research centre of excellence; one which is
tasked with developing a UK and international reputation. It has the

added advantage of being based on a thriving campus working alongside
a first class academic peer group, with Faculty leadership committed
to a strategy centred on high quality research in the field of health
economics. Building a credible team quickly will be critical.

Your reputation in the field will be substantiated by the extent of
your research experience, contribution to publications, visionary
leadership, and potential for developing external collaboration,
income generation, consultancy services and funding. My clients
expect that you will become a 'magnet' for other research
professionals.

This initiative has been welcomed and supported by the NHS, WHO and
others in areas of research who are interested in informed clinical
management strategies and pharmacoeconomics.

Location and the reward package will be important to you, but the key
attraction is the sheer challenge so please only contact me if you are
motivated to be well respected to create and innovate.

For a confidential discussion please contact Neil Sampson, Consultant,
TMP Worldwide - Executive Resourcing on 0207 872 1610 (days) or 01494
725176 (evenings/weekends) or email nsampson@tmpw.co.uk.


---------------------------------

WORLD BANK

Economist (Health) AFRICA

The World Bank is seeking a highly qualified health economist as part
of a general strengthening of the Africa region's economic and
strategic capacity.

Based in Washington D.C., the economist will be a member of the
Africa Technical Human Development Unit (AFTH2) which covers 16
countries in west and central Africa: Cameroon, Cape Verde, Central
African Republic, Chad, Congo-Brazzaville, Gabon, The Gambia, Guinea,
Guinea-Bissau, Equatorial Guinea, Liberia, Mali, Mauritania, Sao Tome
and Principe, Senegal and Sierra Leone. The Unit focuses on the
Education, Health, Nutrition, Population and Social Protection
sectors and works with country teams on a variety of lending and
non-lending tasks. It is responsible for about one third of the
volume of the Africa region's Human Development (HD) activities.

The unit has an active and growing portfolio in health, with an
increasing proportion of sectorwide operations. The work of the
health economist will complement that of the unit's public
expenditure economist who currently works with both the education and
health sectors. The successful candidate will also contribute to an
improved strategic HD focus, along with that of an education
economist being recruited simultaneously. It is also the AFTH2
manager's policy to encourage all staff to spend 10-20% of their time
on tasks outside the Africa region.


The position is initially in Washington, but relocation to Dakar is
possible in the future in line with the Africa Region's
decentralization policy.

Duties and Accountabilities:

The health economist will carry out work on a broad range of issues
related to the reform and strengthening of health delivery, health
financing (including cost recovery and affordability), health
microeconomics and the integration of health into Bank country
assistance strategies. Specific duties and accountabilities include:

* Designing, preparing and managing health tasks (lending and sector
work) in a participatory fashion in one or more of the above
countries;

* Representing the health sector on some country teams, especially in
developing country economic analyses and the country assistance
strategy;

* Contributing to regional and Bank strategy development and knowledge
management

Selection Criteria :

Personal commitment to fight poverty.

Advanced university degree in health economics, or in economics with
substantial
Experience in the health sector.

At least 5 years experience of health economics in developing
countries, preferably including Africa and preferably including also
leadership or participation in the design and implementation of
health projects.

Strong analytical capacity with demonstrated experience in sectoral

analysis, health financing including cost recovery), health strategy
and policy formulation, and the use of household data; familiarity
with national health accounts, provider payment systems, pricing
policies and cost-effectiveness of interventions.

Ability to interact effectively and in a participatory way with a
full range of stakeholders, including Bank colleagues, government
counterparts, donor and UN representatives, NGOs and community-based
organizations.

Demonstrated ability to work in multidisciplinary teams.

Demonstrated political sensitivity to country working environments.

Excellent oral and written communication skills in English and in French.
Portuguese useful but not required.

Willingness to undertake considerable mission travel, coupled with a high
tolerance for uncertainty.

Women and nationals of developing countries are strongly encouraged
to apply. The World Bank offers an internationally competitive
compensation package. Candidates should send a detailed curriculum
vitae by October, 16, 2000, to mreinauer@worldbank.org or The World
Bank, Room G-7-053, 1818 H St, NW, Washington, DC 20433. Fax:
202-522-7246


SENIOR HEALTH ECONOMIST - PHARMACEUTICALS

The World Bank is seeking a Senior Health Economist with expertise in
pharmaceuticals to join the the Health, Nutrition, and Population (HNP)
team of the Human Development Network. This is a three-year contract
based in Washington D.C.

The World Bank's purpose is to help borrowers reduce poverty and improve
living standards through sustainable growth and investment in people.
The World Bank has a large and growing portfolio of activities in the
Health, Nutrition and Population sector. Under the leadership of the
Director, the HNP team supports the Bank's work in the sector by i)
strengthening sectoral strategies; ii) enhancing the quality of products;
iii) sharing relevant knowledge and experience; iv) supporting
professional excellence through formal and just-in-time training;
and v) establishing and enhancing external partnerships.

Duties and Accountabilities

The health economist will focus on pharmaceutical issues in developing
countries as they relate to broader health systems development.
S/he will be responsible for leading major pieces of global analytical
work on pharmaceutical issues as well as contributing to country level
policy dialogue and lending operations. The health economist will also
liaise with international organizations, such as WHO, UNICEF, IFPMA,
UNFPA, and UNAIDS on pharmaceutical issues. Specific duties include
the following:

Providing guidance and strategic direction to Bank management, task teams,
and client countries on pharmaceutical policies, covering essential drug
lists, pharmaceutical procurement, pharmaceutical regulation, the rational
use of drugs, pharmaceutical supply and distribution issues, and
pricing and reimbursement;

Monitoring what types of support the Bank is providing (or not
providing) in
pharmaceuticals and leading efforts to improve the nature and
quality of such support;

Designing pharmaceutical components within Bank-financed health
projects or freestanding pharmaceutical projects;

Organizing training for staff on key pharmaceutical issues, providing
relevant learning materials on the web (such as case studies and key
policy documents) for staff in the pharmaceutical area. Assisting
in identifying pharmaceutical consultants;

Liaising with international organizations, such as WHO, UNICEF,
UNFPA, IFPMA, and UNAIDS to share information and, when appropriate,
harmonizing procedures relating to pharmaceuticals;

Providing analytical support to the Bank's contribution to international
efforts in research and development for new vaccines and drugs that
benefit the poor in developing countries, such as HIV/AIDS microbodies,
HIV/AIDS vaccines, and new medicines for malaria.

Selection Criteria:

Ph.D in economics, health economics, or health policy.


At least eight years' experience working in health economics
preferably in developing countries.

In-depth knowledge and experience in several areas of pharmaceutical
policies, such as cost benefit/effectiveness analysis, pricing and
reimbursement policies, essential drug lists and formularies,
procurement policies, supply and distribution, regulation, rational
use.

Success in working in teams both as a team member and as a team
leader, with a conviction that this combination of roles is desirable
and will continue throughout her/his career.

A record of prioritizing and managing her/his time to deliver high
priority and top quality products, but also an ability to tolerate
and manage significant uncertainties in the work program and to
undertake a range of tasks simultaneously.

Strong conceptual and analytical skills; proven ability to
demonstrate in a tangible and understandable way for non-economists,
how economic analysis can improve the Bank's portfolio and provide
value for governments interested in improving their health policies;
ability to move from analytical models to practical recommendations,
recognizing political, institutional, and behavioral factors.

Excellent written and oral communication skills essential; strong
record of sharing information with colleagues, clients, and
supervisors in performing her/his job; capacity to interact
effectively with a range of stakeholders within and outside the
Bank, with a strong client orientation.

Nationals of developing countries are encouraged to apply. The World Bank
offers a competitive compensation package including relocation benefits.
Interested, qualified candidates should send a detailed curriculum vitae
and cover letter summarizing suitability by September 29, 2000 to:

Mary Amanda Reinauer
World Bank
1818 H St NW
Washington DC 20433
Fax: 202 522-7246

Phone: 202 473-3613

or by email, to mreinauer@worldbank.org



=========================================================================
CONFERENCES
=========================================================================

CHSPR ANNUAL HEALTH POLICY CONFERENCE

Centre for Health Services and Policy Research - 13th Annual Health Policy
Conference: Threats to Quality: Perceived or Real?

Date: Friday November 10th, 2000
Location: University Golf Club, Vancouver, BC

Summary of Conference Theme:

Almost weekly, articles appear in most Canadian newspapers alluding to the
fact that Canadas health system is in an ever worsening "crisis" - unable
to provide consistent quality in the care delivered to meet accepted
standards. Numerous threats are cited including long delays for surgery
and hospitalization, perpetually overcrowded emergency rooms, overworked
and increasingly scarce health care work force, a lack of state-of-the-art
health technologies, and uneven performance by health personnel. CHSPR's
annual policy conference, titled "Threats to Quality: Perceived or Real?"
aims to explore internal tensions at play driving the increased focus on
quality of care, how mechanisms to improve quality have been employed, and
the evidence that these responses are really improving quality. As
examples, we will examine several "hot button" issues - hospital wait
times, primary care, and small area variations in post-hospitalization
outcomes - and examine the evidence that quality problems exist and
potential strategies for quality improvement.

Preliminary List of Speakers:

Keynote Speaker: Alan Maynard, The Nuffield Provincial Hospitals Trust, UK

Panel Speakers:
Elliot Goldner, Mental Health Evaluation and Community Consultation Unit,
UBC
Nick Kates, McMaster University, Ontario
Jack V. Tu, Institute for Clinical Evaluative Sciences, Ontario
Charles Wright, Vancouver Hospital and Health Sciences Centre, BC

Other speakers to be confirmed


For additional information about the conference or if you would like to
receive a copy of the registration materials please contact Juliet Ho
e-mail: jho@chspr.ubc.ca; Tel: 604-822-4969; Fax: 604-8225690.


---------------------------------------

CONSOLIDATION AND COMPETITION IN THE PHARMACEUTICAL INDUSTRY

Office of Health Economics Conference

16 October 2000
at 1 Whitehall Place, London

This OHE conference brings together experts from academia, industry,
the US Federal Trade Commission and the competition directorate of the
European Commission to debate the major public policy issues arising
from the changing R&D process in pharmaceuticals and the changing
structure of the industry.

Many new firms are undertaking R&D, but at the same time we see
consolidation among "big pharma" companies. Will these trends be
sustained and if so what are the implications for policy makers and
competition authorities?

Registration fees for the one-day conference, inclusive of VAT, are
250GBP private sector and 90GBP public and not-for-profit sectors.
To book your place at the conference please contact:

Mrs Elizabeth Aulsford
Office of Health Economics, 12 Whitehall, London, SW1A 2DY

Tel: +44 (0)20 7930 9203 extn.1455
Fax: +44 (0)20 7747 1419
E-mail: laulsford@ohe.org


OHE CONFERENCE PROGRAMME, 16th October 2000

9:30-10:10 Professor John Kay, UK
"Changes in Market Structure - the Economic Issues"

10:10-10:50 Professor Louis Galambos, Department of History, Johns
Hopkins University, Baltimore, Maryland, US
"Global Oligopoly, Regional Authority and National Power: Cross Currents
in Pharmaceuticals Today and Tomorrow"

10:50-11:15 Coffee

11:15-11:55 Dr. Hannah Kettler, Office of Health Economics and Gabby
Ashton, Centre for Medicines Research International, UK
"The Role of the External Network in the Pharmaceutical R&D Process:
Alliances and Licensing Strategies"

11:55-12:35 Professor Fabio Pammolli, Faculty of Economics, University of
Siena, Italy
"Innovation and Markets for Technology in the Pharmaceutical
Industry"

12:35-1:45 Lunch

1:45-2:25 Professor Henry Grabowski, Director of the Program in
Pharmaceuticals and Health Economics, Duke University, North
Carolina, US
"Pressures from the Demand Side: Changing Market Dynamics and Industrial
Structures"

2:25-3:05 Jo Walton, Lehman Brothers, UK
"Investors&Mac226; Views on Merger and Acquisition, Alliance and Licensing
Activity in the Pharmaceutical Industry"

3:05-3:30 Tea

3:30-3:40 Professor George Yarrow, Director of the Research Policy
Institute, Oxford, UK
"How to Regulate Pharmaceutical Companies: Ex Ante or Ex Post?"

3:40-4:10 Professor Jeremy Bulow, Director of the Bureau of Economics,
Federal Trade Commission, Washington DC, US
"Competition Policy Issues for Regulators: an American
Perspective"

4:10-4:40 Kirtikumar Mehta, Director of the Competition Policy Group,
Directorate of Competition, European Commission
"Competition Policy Issues for Regulators: a European
Perspective"

4:40-5:00 Final Discussion


------------------------------------------

MEASURING AND VALUING HEALTH FOR ECONOMIC EVALUATION

A two day course to be held in London, UK.
17/18th October 2000 and 6/7th December 2000.

The Sheffield Health Economics Group at the Sheffield School for Health and
Related Research and Fourth Hurdle Consulting have collaborated to run the
above course. It is intended for people who wish to gain an in depth
understanding of this important area.

Course objectives
The course aims to take students from an introductory level through to an
advanced understanding of the subject. At the end of the course, students
should be able to:

Appreciate the role of HRQoL measurement and valuation in economic
evaluation and submissions to bodies such as NICE.
Be familiar with the main generic instruments used to assess HRQoL and

health state utilities and how to use them
Appreciate the limitations of many measures of HRQoL for use in economic
evaluation
Understand the pros and cons of the key instruments for estimating quality
adjusted life years (QALYs)
Critically review published work
Understand the principles and practicalities of designing their own study

We hope that you will be interested in participating in this course and
also pass the information to colleagues who might also be interested in
attending. For more information on the course and to download the course
brochure and booking form in pdf format please use the link
www.fourthhurdle.com and click on the NOTICE BOARD button. Alternatively
call Alex Sexton at Fourth Hurdle Consulting Ltd. on 44 (0)20 440 4060,
or e-mail her at alexsexton@fourthhurdle.com


------------------------------------

SEVENTH NORTHEAST REGIONAL HEALTH ECONOMICS RESEARCH SYMPOSIUM

Co-Sponsored by:
VA Management Science Group
Boston University School of Public Health, Health Services Department

Held August 17 & 18, 2000 in Newport, RI

Copies of Papers available from the Management Science Group NOW!
If you are interested in getting copies of individual papers from
the Symposium or the whole package of papers, please contact:

Pat Heffernan, VA Management Science Group, 200 Springs Road,
Bedford, MA 01730 USA or by E-Mail: Pat.Heffernan@med.va.gov
or by FAX: +1-781-687-2376. The Management Science Group
runs this conference co-sponsored with Boston University
every other year for Health Economists in the Northeastern
part of the US in alternate years from the worldwide
conference on Industrial Organization in Health Care
which will next be held in September of 2001. A call for
papers for this conference will be forthcoming later in
the year.


SESSION I: HEALTH ECONOMICS THEORY

"Public Rationing and Private Cost Incentives"
Presenter: Albert Ma, Boston University
Discussant: Kevin Frick, Johns Hopkins University

"Health Insurance and Provider Payment System Design:
Multitasking, Competition and Selection"
Presenter: Karen Eggleston, Tufts University
Discussant: Bill Encinosa, Agency for Healthcare Research and Quality

"Managed Competition as a Commitment Mechanism"
Presenter: David Howard, Harvard University
Discussant: Will White, Yale University


SESSION II: MANAGING HEALTH CARE

"HMOs and Risk Selection"
Presenter: Dan Polsky, University of Pennsylvania
Co-author: Sean Nicholson, University of Pennsylvania
Discussant: Jeannette Rogowski, RAND Corporation

"What Factors Influence The Prices Negotiated by HMOs and Hospitals?"
Presenter: Jack Zwanziger, University of Rochester
Co-author: Cathleen Mooney, University of Rochester
Discussant: Carol Simon, Boston University

"Administered Prices and Suboptimal Prevention: The Case of
Outpatient-Inpatient Substitution In the Medicare Dialysis Program"
Presenter: Avi Dor, Case Western Reserve University
Discussant: Dominic Hodgkin, Brandeis University


SESSION III: ANALYTICAL TECHNIQUES

"Lifecycle Changes in the Rate of Time Preference: Testing
the Theory of Endogenous Preferences and Its Relevance to
Adolescent Substance Use"
Presenter: David Bishai, Johns Hopkins University
Discussant: Jim Burgess, VA Management Science Group

"Measurement Errors in Binary Regressors: An Application to
Measuring the Effects of Specific Psychiatric Diseases on Earnings"
Presenter: Elizabeth Savoca, Smith College
Discussant: Partha Deb, IUPUI

"Nonparametric Analysis of Returns to Scale and Product Mix
among US Hospitals"
Presenter: Paul Wilson, University of Texas
Co-author: Kathleen Carey, VA Management Science Group
Discussant: Will Manning, University of Chicago


=========================================================================
FORTHCOMING ARTICLES
=========================================================================

HEALTH ECONOMICS VOL. 9(5) JULY 2000


Mooney, G. and Wiseman, V.
Burden of disease and priority setting

Healey, A., Mirandola, M., Amaddeo, F., Bonizzato, P. and Tansella, M.
Using health production functions to evaluate treatment
effectiveness: an application to a community mental health service

Bryan, S., Gold, L., Sheldon, R. and Buxton, M.
Preference measurement using conjoint methods: an empirical
investigation of reliability

Andersen, C.K., Andersen, K. and Kragh-Sorensen, P.
Cost function estimation: the choice of a model to apply to dementia

MacIntyre, C.R., Plant, A.J. and Hendrie, D.
The cost-effectiveness of evidence-based guidelines and practice
for screening and prevention of tuberculosis

Freiman, M.P. and Zuvekas, S.H.
Determinants of ambulatory treatment mode for mental illness

Carey, K.
A multilevel modelling approach to analysis of patient costs under
managed care

Grytten, J. and Sorensen, R.
Competition and dental services

------------------------------

JOURNAL OF HEALTH ECONOMICS, VOL 19 (5), SEPT 2000

Equity in the delivery of health care in Europe and the US
E. van Doorslaer, A. Wagstaff, H. van der Burg, T. Christiansen, D. De
Graeve, I. Duchesne, U.-G. Gerdtham, M. Gerfin, J. Geurts, L. Gross,
U. Hakkinen, J. John, J. Klavus, R.E. Leu, B. Nolan, O. O'Donnell, C.
Propper, F. Puffer, M. Schellhorn, G. Sundberg, O. Winkelhake

Optimal health insurance: the case of observable, severe illness
M.E. Chernew, W.E. Encinosa, R.A. Hirth

The family as producer of health - an extended grossman model
L. Jacobson

Moral hazard in physician prescription behavior
D. Lundin

Contracts for health care and asymmetric information
G. De Fraja

Health care expenditure in the last months of life
S. Felder, M. Meier, H. Schmitt

Standard errors for the retransformation problem with
heteroscedasticity
C. Ai, E.C. Norton

Health care evaluation, utilitarianism and distortionary taxes
P. Calcott

Consumer satisfaction and supplier induced demand
F. Carlsen, J. Grytten

Incorporating option values into the economic evaluation of health
care technologies S. Palmer, P.C. Smith

Hospital mergers and acquisitions: does market consolidation harm
patients? V. Ho, B.H. Hamilton

HMO penetration and the geographic mobility of practicing physicians
D. Polsky, P.R. Kletke, G.D. Wozniak, J.J. Escarce

Correction note on ''The demand for health with uncertainty and
insurance''
K. Tabata, Y. Ohkusa

Insurance and imperfect financial markets in Grossman's demand for
health model - a reply to Tabata and Ohkusa
B. Liljas


--------------------------------------

HEALTH CARE MANAGEMENT SCIENCE

Health Care Management Science 3 (2000) 3

Edward H. Kaplan and Mira Johri
Treatment on demand: an operational model

E. Kathleen Adams, Patrick D. Mauldin, Jill G. Mauldin and Robert M.
Mayberry
Determining cost savings from attempted cephalic version in an inner
city delivering population

Huguette Beaulieu, Jacques A. Ferland, Bernard Gendron and Philippe
Michelon
A mathematical programming approach for scheduling physicians in the
emergency room

Manuel D. Rossetti, Robin A. Felder and Amit Kumar
Simulation of robotic courier deliveries in hospital distribution
services

Fsun F. Gnl, Franklin Carter and Jerry Wind
What kind of patients and physicians value direct-to-consumer
advertising of prescription drugs

Timothy W. Butler and G. Keong Leong
The impact of operations competitive priorities on hospital performance

P.S. Raju, Subhash C. Lonial, Yash P. Gupta and Craig Ziegler
The relationship between market orientation and performance in the
hospital industry: A structural equations modeling
approach

Steffen Flessa
Where efficiency saves lives: A linear programme for the optimal
allocation of health care resources in developing
countries


=========================================================================
SUBSCRIPTION AND MEMBERSHIP INFORMATION
=========================================================================



A subscription to iHEA NEWS is included as a benefit of membership in
iHEA.


iHEA has been formed to increase communication among health
economists, foster a higher standard of debate in the application
of economics to health and health care systems, and assist young
researchers at the start of their careers. Activities of the
association include:


- Present the annual "Kenneth J. Arrow Award for Best Paper in Health
Economics."


- Hold biennial conferences, the first May 19-23, 1996 in Vancouver,
B.C. (640 delegates attended), and the second in June 6-9 1999 at
Erasmus University, Rotterdam, the third July 11 - 25, 2001 at
CHE, York, England.


- Assist in the distribution of Journal of Health Economics and Health
Economics, and provide both publications at discounts to members.


- Publish a biannual newsletter, HEAL (Health Economics Analysis
Letters), and a monthly electronic newsletter, iHEA NEWS
listing upcoming meetings, recent paper presentations, jobs,
and professional commentary.


- Publish a series of books in health economics and a World Directory
of Health Economists listing individuals and organizations.


- Assist in the distribution of eHEL, electronic Health Economics
Letters, an electronic journal with internet dissemination
and peer-review of economic studies of policy, effectiveness,
technology, market structures and pharmaceuticals around the world.



The association will be involved in organizing other conferences and
sessions at affiliated meetings, obtaining peer-reviewers for journals and
grants, and similar professional activities. The current officers are:

Thomas E. Getzen, Executive Director
Bill Swan, Associate Director

Mark V. Pauly, President
Frans Rutten, President Elect
Joseph P. Newhouse, Past President
Michael A. Morrisey, Secretary/Treasurer
W. David Bradford, Co-Editor, iHEA News
James F. Burgess, Jr., Co-Editor, iHEA News

Peter Zweifel, Director, 2000-2001
Patricia M. Danzon, Director, 2000-2001
Judith R. Lave, Director, 2000-2001
Frank Sloan, Director, 2000-2002
Jacques van der Gaag, Director, 2000-2002
Barbara (Bobbi) Wolfe, Director, 2000-2002

Michael Drummond, Program Chair, York 2001
Richard Scheffler, Program Chair, San Francisco 2003

Other sponsoring universities and organizations
include Abt Associates, Inc.; American Medical Association; Barents Group,
LLC; The MEDSTAT Group, Inc.; RAND Corporation; John Wiley and Sons, Ltd.;
Carnegie Mellon University; Harvard University; London School of Hygiene
and Tropical Medicine; University of Alabama at Birmingham; University of
Illinois at Urbana/Champaign; University of Pennsylvania; University of
Michigan; VA Management Science Group; Mustard Seed Inc., and U.S.
Healthcare Corporation.


To join as a member of iHEA, fill in the form below and send
in by e-mail or fax. For further information please contact:


Bill Swan
Associate Director - International Health Economics Association
3rd Floor, Abramsky Hall, Queen's University
Kingston, Ontario K7L 3N6 CANADA
(613) 533-6675 Tel
(613) 533-6353 Fax
swanb@post.queensu.ca


___cut___cut______cut_____cut______cut____cut______cut______



International Health Economics Association (iHEA)


Application for Membership
__________________________________________________


Some genders are difficult to establish from the titles Professor
and Dr. Please indicate your gender if you feel this may be an
issue with your name:


[ ] Male [ ] Female


Title:
First name (and initials):
Last name:
Degree(s):
Nickname:


Current Position:



Organization:



Department:


Mailing Address
Office/Suite Number: Street Number:
Street Name:
City: State/Province:
Postal/Zip Code:

Country:


This is my Office Home address.


Other Affiliation(s):


Telephone (please include country code)
Office: ( ) extension:
Fax: ( )
Home: ( )
E-mail Address:
Web Page Address:



List up to 8 keywords indicating your primary interests:



Any additional information to be listed with your directory listing:



Do you wish to have a listing in our membership directory?
[ ] Yes [ ] No



Amount charged:


[ ] : ($50 US) 2000 Membership in iHEA incl. subscription to HEAL
newsletter and listing in directory
[ ] : ($750 US) 2000 Academic/Non-Profit Membership in iHEA.
[ ] : ($2000 US) 2000 Corporate Membership in iHEA
[ ] : ($10,000 US) Supporting Membership in iHEA for 2000


Note: You must be a paid member to receive discounted subscription rates.


[ ] : ($80 US) personal member's subscription to Journal of Health
Economics for 2000, Volume 19.


[ ] : ($85 US) personal member's subscription to Health Economics for
2000, Volume 9.

[ ] : ($50 US) personal member's subscription to Mental Health Policy
and Economics for 2000, Volume 2.


Total to be billed:


Please select the payment option you will be using:


[ ] Visa
[ ] MasterCard or
[ ] Cheque payable to "iHEA" in $US (Cheques and Money Orders must be
drawn on a US institution)


Card Number:
Expiry Date:
Name on Card:



NOTE: iHEA cannot guarantee the security of your credit card information
sent by e-mail. If you are concerned about Internet security, simply
indicate the amount and type of charges below and mail or fax your
payment separately.


NOTE: MEMBERSHIP DUES AND JOURNAL SUBSCRIPTION COSTS ARE
SUBJECT TO INCREASE WITHOUT NOTICE





FAX, E-MAIL OR SEND TO:


Bill Swan
Associate Director - International Health Economics Association
3rd Floor, Abramsky Hall, Queen's University
Kingston, Ontario K7L 3N6 CANADA
(613) 533-6675 Tel
(613) 533-6353 Fax
swanb@post.queensu.ca
iHEA Web Site: http://www.healtheconomics.org/
_______________________________________________________________________
iHEA is a charitable 501(c)3 non-profit corporation.


=========================================================
W. David Bradford
Associate Professor

Center for Health Care Research
Medical University of South Carolina
135 Rutledge Avenue, Room 1201
PO Box 250550
Charleston, SC 29425

Phone: 843-876-1209
Fax: 843-876-1201
E-mail: bradfowd@musc.edu
=========================================================